Overview of Dr. Monahan
RADM Brian P Monahan is The Attending Physician of The United States Congress responsible for medical care for the Legislative Branch of the US Government and the United States Supreme Court. He is a Hematologist and Medical Oncologist in Washington, DC, and is affiliated with multiple hospitals in the area, including Walter Reed National Military Medical Center and George Washington University Hospital. He is a Professor of Medicine and Pathology at the Uniformed Services University of The Health Sciences. He received his medical degree from Georgetown University School of Medicine and has been in practice 31 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Office
United States Congress H166 US Capitol
Washington, DC 20515Fax+1 202-225-3396
Education & Training
- National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1996
- National Capital ConsortiumChief Residency, Internal Medicine, 1991 - 1992
- National Capital ConsortiumResidency, Internal Medicine, 1989 - 1991
- National Capital ConsortiumInternship, Internal Medicine, 1986 - 1987
- Georgetown University School of MedicineClass of 1986
Certifications & Licensure
- MD State Medical License 1987 - 2025
- DC State Medical License 2010 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow Royal College of Physicians-London
- Master American College of Physicians
Clinical Trials
Publications & Presentations
PubMed
- 6 citationsImplementation of an Alcohol Medical Amnesty Policy at an Urban University With a Collegiate-Based Emergency Medical Services Agency.Brian Monahan, Jose V. Nable, Vince WinklerPrins
The Journal of Adolescent Health. 2019-01-01 - 6 citationsA phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult p...Maurice A. Wright, Geraldine Morrison, Pengxin Lin, Gregory D. Leonard, Dat Nguyen
Clinical Cancer Research. 2005-06-01 - 214 citationsRituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor...John C. Byrd, Jamie K. Waselenko, Thomas J. Maneatis, Timothy Murphy, Frank T. Ward
Journal of Clinical Oncology. 1999-03-01
Journal Articles
- Louis R. Cantilena, Jr. :A Pioneer in Drug SafetyMonahan BP, Pharos, 2/16/2021
Press Mentions
- Rep. Stephen Lynch Contracts Covid Despite Taking Both Doses of Pfizer VaccineJanuary 31st, 2021
- Hoyer Reverses Course, Says House Will Not Return Next Week After Consulting with Capitol PhysicianApril 28th, 2020
- Are Nevada Hospitals Prepared for COVID-19?March 13th, 2020
- Join now to see all
Professional Memberships
- Member
- Master
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: